Skip to main content
. 2011 Oct 11;2011:219268. doi: 10.1155/2011/219268

Table 3.

Cardiometabolic biomarkers at baseline and at 10 months for the intervention and control groups with all intervention subjects included regardless of attendance at the PA sessions (unadjusted mean [SD]).

Variable Baseline 10 Months Adjusted change (SE)* P value
Intervention Control Intervention Control
Insulin, pmol/L 119.4 (84.8) 101.4 (59.9) 130.6 (79.7) 122.4 (57.1) −3.6 (8.9) 0.69
Glucose, mmol/L 4.89 (0.39) 4.91 (0.43) 4.85 (0.37) 4.89 (0.38) −0.03 (0.06) 0.63
SBP, mm Hg 104.1 (7.5) 102.4 (9.1) 105.1 (8.3) 103.8 (7.6) 0.5 (1.0) 0.64
DBP, mm Hg 59.0 (5.6) 59.5 (5.7) 58.3 (6.5) 58.8 (5.4) −0.3 (0.8) 0.72
HR, bpm 79.6 (9.2) 79.8 (8.9) 74.1 (8.9) 76.9 (8.3) −2.7 (1.1) 0.01
TC, mmol/L 4.18 (0.83) 4.15 (0.70) 4.01 (0.74) 4.15 (0.67) −0.15 (0.09) 0.08
TG, mmol/L 0.66 (0.30) 0.63 (0.30) 0.77 (0.37) 0.71 (0.32) 0.04 (0.05) 0.46
HDLC, mmol/L 1.34 (0.32) 1.29 (0.28) 1.36 (0.31) 1.34 (0.31) −0.01 (0.04) 0.73
LDLC, mmol/L 2.67 (0.85) 2.67 (0.69) 2.47 (0.70) 2.67 (0.75) −0.20 (0.10) 0.04
LP(a), mg/dL 45.5 (30.1) 50.6 (42.8) 47.8 (31.1) 57.3 (48.1) −4.48 (3.59) 0.21
LDL size, nm 26.1 (0.69) 26.2 (0.69) 25.7 (0.82) 25.8 (0.72) −0.09 (0.14) 0.50
%HDL2 36.9 (20.3) 36.7 (20.2) 36.1 (20.3) 35.8 (17.6) 0.17 (3.30) 0.96
ApoA1, mg/dL 132.8 (32.3) 124.3 (22.7) 126.2 (22.1) 125.3 (20.7) −1.31 (3.68) 0.72
ApoB, mg/dL 77.6 (29.9) 77.3 (26.1) 71.9 (26.6) 74.1 (21.9) −2.3 (4.3) 0.60
ApoCIII, ng/mL 12.0 (3.8) 11.4 (3.9) 11.1 (4.2) 11.5 (4.3) −0.62 (0.69) 0.37
ApoE, ng/mL 5.26 (1.49) 5.03 (1.75) 5.04 (1.56) 4.78 (1.56) 0.09 (0.20) 0.66
CRP, ng/mL 757.3 (1571.0) 694.2 (883.6) 597.9 (1333.7) 795.8 (1120.5) −245.8 (145.2) 0.09
Fibrinogen, mg/dL 2.72 (0.51) 2.77 (0.55) 2.89 (0.50) 2.91 (0.60) 0.02 (0.08) 0.83

SD: standard deviation; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; TC: total cholesterol; TG: triglycerides; HDLC: high-density lipoprotein cholesterol; LDLC: low-density lipoprotein cholesterol; Lp(a): lipoprotein(a); VLDL: very low-density lipoprotein; Apo: apolipoprotein; CRP: C-reactive protein.

*Change estimates and standard errors (SE) are the differences between intervention and control groups adjusted for age and baseline value.

Intervention N = 74, Control N = 60.

Intervention N = 118, Control N = 82.